ApexNews
Return to Main
Book

Drugs, Money, and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices

2019

Synopsis

In the warped world of prescription drug pricing, generic drugs can cost more than branded ones, old drugs can be relaunched at astronomical prices, and low-cost options are shut out of the market. In Drugs, Money and Secret Handshakes, Robin Feldman shines a light into the dark corners of the pharmaceutical industry to expose a web of shadowy deals in which higher-priced drugs receive favorable treatment and patients are channeled toward the most expensive medicines. At the center of this web are the highly secretive middle players who establish coverage levels for patients and negotiate with drug companies. By offering lucrative payments to these middle players (as well as to doctors and hospitals), drug companies ensure that inexpensive drugs never gain traction. This system of perverse incentives has delivered the kind of exorbitant drug prices - and profits - that everyone loves except for those who pay the bills.

Suggested Reading

Generation Priced Out: Who Gets to Live in the New Urban America

Generation Priced Out is a call to action on one of the most talked-about issues of our time: how skyrocketing rents and home values are pricing the working and middle classes out of urban America. Randy Shaw tells the powerful stories of tenants, politicians, homeowner groups, developers, and activ...

View Details

Drug Wars: How Big Pharma Raises Prices and Keeps Generics off the Market

While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frond...

View Details

Latest News

April 24th, 2026

Senate Republicans Block Sanders Amendment to Cut US Drug Prices by More Than 50%

February 22nd, 2022

This Is How Big Pharma Wins Two years into the pandemic, the industry has evaded reforms a supermajority of voters want.

We use cookies to improve your experience on our website. By continuing to browse, you accept our Cookie Policy and Privacy Policy.